Juvaris BioTherapeutics' Series B Round

Juvaris BioTherapeutics raised a round of funding on September 24, 2009.

Juvaris BioTherapeutics, Inc. is developing adjuvanted vaccines and immunotherapeutics to treat infectious disease and cancer. The Company's platform technology induces immunostimulation via cationic…

Articles about Juvaris BioTherapeutics' Series B Round: